TY - JOUR
T1 - Practical recommendations for population PK studies with sampling time errors
AU - Choi, Leena
AU - Crainiceanu, Ciprian M.
AU - Caffo, Brian S.
N1 - Funding Information:
Acknowledgments This study was supported by R21 AG034412, a grant funded by the National Institute on Aging in the National Institute of Health. We thank Mr. Ronald Caffo for editorial help.
PY - 2013/12
Y1 - 2013/12
N2 - Purpose: Population pharmacokinetic (PK) data collected from routine clinical practice offers a rich source of valuable information. However, in observational population PK data, accurate time information for blood samples is often missing, resulting in measurement errors (ME) in the sampling time variable. The goal of this study was to investigate the effects on model parameters when a scheduled time is used instead of the actual blood sampling time, and to proposeME correction methods. Methods: Simulation studies were conducted based on two major factors: the curvature in PK profiles and the size of ME. As ME correction methods, transform both sides (TBS) models were developed with application of Box-Cox power transformation and Taylor expansion. The TBS models were compared to a conventional population PK model using simulations. Results: The most important determinant of bias due to time ME was the degree of curvature (nonlinearity) in PK profiles; the smaller the curvature around sampling times, the smaller the associated bias. The second important determinant was the magnitude of ME; the larger the ME, the larger the bias. The proposed TBS models performed better than a conventional population PK modeling when curvature and ME were substantial. Conclusions: Time ME in sampling time can lead to bias on the parameter estimators. The following practical recommendations are provided: 1) when the curvature of PK profiles is small, conventional population PK modeling is robust to even large ME; and 2) when the curvature is moderate or large, the proposed methodology reduces bias in parameter estimates.
AB - Purpose: Population pharmacokinetic (PK) data collected from routine clinical practice offers a rich source of valuable information. However, in observational population PK data, accurate time information for blood samples is often missing, resulting in measurement errors (ME) in the sampling time variable. The goal of this study was to investigate the effects on model parameters when a scheduled time is used instead of the actual blood sampling time, and to proposeME correction methods. Methods: Simulation studies were conducted based on two major factors: the curvature in PK profiles and the size of ME. As ME correction methods, transform both sides (TBS) models were developed with application of Box-Cox power transformation and Taylor expansion. The TBS models were compared to a conventional population PK model using simulations. Results: The most important determinant of bias due to time ME was the degree of curvature (nonlinearity) in PK profiles; the smaller the curvature around sampling times, the smaller the associated bias. The second important determinant was the magnitude of ME; the larger the ME, the larger the bias. The proposed TBS models performed better than a conventional population PK modeling when curvature and ME were substantial. Conclusions: Time ME in sampling time can lead to bias on the parameter estimators. The following practical recommendations are provided: 1) when the curvature of PK profiles is small, conventional population PK modeling is robust to even large ME; and 2) when the curvature is moderate or large, the proposed methodology reduces bias in parameter estimates.
KW - Berkson error
KW - Blood sampling design
KW - Blood sampling time
KW - Measurement error
KW - Nonlinearmixed effectmodel
KW - Pharmacokinetic
UR - http://www.scopus.com/inward/record.url?scp=84892369834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892369834&partnerID=8YFLogxK
U2 - 10.1007/s00228-013-1576-7
DO - 10.1007/s00228-013-1576-7
M3 - Article
C2 - 23975237
AN - SCOPUS:84892369834
SN - 0031-6970
VL - 69
SP - 2055
EP - 2064
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
IS - 12
ER -